More patients to access pembrolizumab

Govt broadens indications for people with advanced non-small cell lung cancer

The number of patients with metastatic non-small cell lung cancer eligible for subsidised treatment with pembrolizumab is set to triple, the federal Minister for Health, Greg Hunt, has announced.

Medicare card and bank notes in background

In a move expected to benefit 4000 Australians with advanced disease, he has approved two new PBS indications and loosened restrictions on an existing indication.

Here are the indications for previously untreated patients with metastatic disease:

  1. In non-squamous non-small cell lung cancer (NSCLC)

Latest

Trending